Beijing Northland Biotech. Co., Ltd. – PeptideBlog

Beijing Northland Biotech. Co., Ltd.

Beijing Northland Biotech. Co., Ltd.

2 registered trials on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.

Compounds covered

Registered trials

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers
NCT04555824
TB-500Phase 1CompletedBeijing Northland Biotech. Co., Ltd.54Feb 20, 2018Sep 29, 2020
A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers
NCT04555850
TB-500Phase 1CompletedBeijing Northland Biotech. Co., Ltd.30Feb 18, 2019Sep 29, 2020

Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.